Felisita T. Ratu

Suva, C, Fiji

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

The impact of 10-valent pneumococcal vaccine introduction on invasive disease in Fiji.

The impact of 10-valent pneumococcal vaccine introduction on invasive disease in Fiji.

Journal: The Lancet regional health. Western Pacific
Published: January 14, 2022

Direct and indirect effects of COVID-19 on perinatal outcomes in low- and middle-income countries.

Direct and indirect effects of COVID-19 on perinatal outcomes in low- and middle-income countries.

Journal: Gates open research
Published: March 16, 2021

Genotype Diversity before and after the Introduction of a Rotavirus Vaccine into the National Immunisation Program in Fiji.

Genotype Diversity before and after the Introduction of a Rotavirus Vaccine into the National Immunisation Program in Fiji.

Journal: Pathogens (Basel, Switzerland)
Published: February 08, 2021

The Challenges of Using Oropharyngeal Samples To Measure Pneumococcal Carriage in Adults.

The Challenges of Using Oropharyngeal Samples To Measure Pneumococcal Carriage in Adults.

Journal: mSphere
Published: July 31, 2020

The impact of the rotavirus vaccine on diarrhoea, five years following national introduction in Fiji.

The impact of the rotavirus vaccine on diarrhoea, five years following national introduction in Fiji.

Journal: The Lancet regional health. Western Pacific
Published: June 03, 2020

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis.

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis.

Journal: The Lancet. Global health
Published: March 04, 2020

Predictors of antibody persistence to the 7-valent pneumococcal conjugate vaccine in healthy Fijian infants at 12 months of age.

Predictors of antibody persistence to the 7-valent pneumococcal conjugate vaccine in healthy Fijian infants at 12 months of age.

Journal: Vaccine
Published: March 02, 2020

Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules.

Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules.

Journal: Vaccines
Published: November 06, 2019

Associations between ethnicity, social contact, and pneumococcal carriage three years post-PCV10 in Fiji.

Associations between ethnicity, social contact, and pneumococcal carriage three years post-PCV10 in Fiji.

Journal: Vaccine
Published: May 31, 2019

The association between pneumococcal vaccination, ethnicity, and the nasopharyngeal microbiota of children in Fiji.

The association between pneumococcal vaccination, ethnicity, and the nasopharyngeal microbiota of children in Fiji.

Journal: Microbiome
Published: October 05, 2018

Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine.

Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine.

Journal: Open forum infectious diseases
Published: May 03, 2018

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys.

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys.

Journal: The Lancet. Global health
Published: February 22, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026